Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | ENESTnd: results from an exploratory biomarker analysis in CML

Jerald P. Radich, MD, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, elaborates on the exploratory biomarker analysis results from the ENESTnd trial (NCT00471497). In this study, it was determined that gene expression signatures can distinguish deep molecular responses from poor response in chronic myeloid leukemia (CML). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).”